Congress funds global maternal health with clear targets and annual accountability.
H.R. 9583 — Healthy Mothers, Healthy Babies Act of 2026 · Filed by Young Kim (R-CA) · 3 cosponsors · Introduced Jul 2, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes up to $150 million annually through 2030 to help low-income countries scale up access to multiple micronutrient (MMS) prenatal vitamins and other proven maternal and child health interventions. The bill directs the State Department to select priority countries based on malnutrition rates and need, establish a 5-year strategy with measurable targets, and report annually on progress toward reducing preventable maternal and child deaths.
Why we flagged it
The bill is a straightforward foreign assistance authorization for maternal and child health programs, with specific focus on micronutrient supplementation. It allocates federal funds to a defined public health objective with reporting requirements and measurable targets.
What the text implies
- The bill's emphasis on MMS prenatal vitamins (mentioned 11 times in findings) combined with the note that 'MMS prenatal vitamins are American-made' and a $250M philanthropic commitment suggests potential indirect benefit to U.S. manufacturers, though no direct subsidy or procurement mandate is stated.
- Reporting requirements and 'common set budget tags' may create administrative burden on foreign assistance agencies but improve transparency and accountability for Congress.
The full analysis lists 3 implications of this text.
Who stands to gain
U.S. manufacturers of micronutrient supplements (indirect, via increased global demand); International health organizations (Gavi, implementing partners receiving grants)